GLP-1 R (24mg)

Retatrutide (24mg)
Retatrutide is a cutting-edge multi-agonist peptide designed to support advanced metabolic regulation. As a triple receptor agonist (GLP-1, GIP, and glucagon), it represents the next generation in weight management and body composition optimization.

This 24mg lyophilized peptide offers strong potential in areas such as appetite modulation, insulin sensitivity, fat metabolism, and overall energy balance. Early studies indicate superior efficacy compared to traditional GLP-1 agonists, positioning Retatrutide as a powerful tool in metabolic and endocrine-focused protocols.

Compounded to the highest purity standards, this formulation is ideal for physicians and practitioners operating in performance, longevity, and functional medicine settings seeking novel approaches to support patients with weight, insulin, and energy regulation challenges.

Key Features:

24mg lyophilized peptide for stable, long-term storage and flexible dosing

Multi-pathway action: GLP-1, GIP, and glucagon receptor engagement

Supports enhanced satiety, insulin sensitivity, and metabolic rate

Compounded in the USA using pharmaceutical-grade materials

Extended 2–3 year BUD when stored properly in dry, cool conditions

Intended for qualified clinical use under physician direction. Not for resale or consumer self-administration.